收藏切换
Effect of daggligin combined with levosimendan on elderly patients with heart failure with reduced ejection fraction
收藏切换
Yongqiang XIAO, Jiwei HUANG
World Clinical Drug | 2023, 44(5) : 477 - 482
Less
收藏切换
World Clinical Drug | 2023, 44(5): 477-482
• Article •
Effect of daggligin combined with levosimendan on elderly patients with heart failure with reduced ejection fraction
Full
Yongqiang XIAO, Jiwei HUANG
Affiliations
  • Department of Cardiovascular Medicine, Zigong First People's Hospital, Zigong 643000, Sichuan Province, China
Published: 2023-05-10 doi: 10.13683/j.wph.2023.05.012
Outline
收藏切换
Objective

To analyze the effect of dapagliflozin combined with levosimendan in the treatment of elderly patients with heart failure with reduced ejection fraction (HFrEF).

Methods

A total of 144 elderly patients with HFrEF in our hospital from July 2019 to July 2022 were selected and randomly divided into the study group and the control group, with 72 cases in each group. The control group was given levosimendan, and the study group was given dapagliflozin on the basis of the control group. The treatment effects and adverse reactions of the two groups were compared. Myocardial microcirculation indexes [(total myocardial ischemia load, frequency and duration of ST segment decline)], oxidation/antioxidant balance index [malondialdehyde (MDA), superoxide dismutase (SOD), lipid peroxide (LPO), glutathione peroxidase (GSH-Px)] were detected before and after treatment. The both groups were followed up for 6 months and the readmission rate was counted.

Results

The total effective rate of the study group was 95.83%, which was higher than 86.11% of the control group (P<0.05). After treatment, the total myocardial ischemia load, frequency and duration of ST segment decline, MDA and LPO in the two groups significantly decreased compared with those before treatment, and those in the study group was lower than those in the control group (P<0.05). After treatment serum SOD and GSH-Px in the two groups were higher than those before treatment, and those in the study group were higher than those in the control group (P<0.05). There was no statistically significant difference in adverse reactions between the two groups (8.33% vs 5.56%, P>0.05).

Conclusion

Dapagliflozin combined with levosimendan is effective, safe and reliable in the treatment of elderly HFrEF patients, which is helpful to correct the oxidation/antioxidant balance and improve myocardial microcirculation.

heart failure with reduced ejection fraction  /  elderly  /  dapagliflozin  /  levosimendan  /  myocardial microcirculation
肖勇强, 黄纪卫. 达格列净联合左西孟旦治疗老年射血分数减低型心力衰竭患者的效果. 世界临床药物, 2023 , 44 (5) : 477 -482 . DOI: 10.13683/j.wph.2023.05.012
Yongqiang XIAO, Jiwei HUANG. Effect of daggligin combined with levosimendan on elderly patients with heart failure with reduced ejection fraction[J]. World Clinical Drug, 2023 , 44 (5) : 477 -482 . DOI: 10.13683/j.wph.2023.05.012
Year 2023 volume 44 Issue 5
14
3
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2023.05.012
  • Receive Date:2022-11-03
  • Online Date:2026-11-18
  • Published:2023-05-10
Article Data
Affiliations
History
  • Received:2022-11-03
Funding
Affiliations
    Department of Cardiovascular Medicine, Zigong First People's Hospital, Zigong 643000, Sichuan Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2023.05.012
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT